These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 10509562

  • 1. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L, Eagling VA, Back DJ.
    AIDS; 1999 Sep 10; 13(13):1623-7. PubMed ID: 10509562
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA, Profit L, Back DJ.
    Br J Clin Pharmacol; 1999 Oct 10; 48(4):543-52. PubMed ID: 10583025
    [Abstract] [Full Text] [Related]

  • 3. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
    Lucia MB, Rutella S, Leone G, Vella S, Cauda R.
    J Acquir Immune Defic Syndr; 2001 Aug 01; 27(4):321-30. PubMed ID: 11468419
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
    Jones K, Bray PG, Khoo SH, Davey RA, Meaden ER, Ward SA, Back DJ.
    AIDS; 2001 Jul 27; 15(11):1353-8. PubMed ID: 11504956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD.
    AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145
    [Abstract] [Full Text] [Related]

  • 12. HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.
    Drewe J, Gutmann H, Fricker G, Török M, Beglinger C, Huwyler J.
    Biochem Pharmacol; 1999 May 15; 57(10):1147-52. PubMed ID: 11230802
    [Abstract] [Full Text] [Related]

  • 13. Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
    Rouquayrol M, Gaucher B, Roche D, Greiner J, Vierling P.
    Pharm Res; 2002 Nov 15; 19(11):1704-12. PubMed ID: 12458677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.
    Perloff MD, von Moltke LL, Fahey JM, Daily JP, Greenblatt DJ.
    AIDS; 2000 Jun 16; 14(9):1287-9. PubMed ID: 10894301
    [No Abstract] [Full Text] [Related]

  • 18. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
    Schütt M, Zhou J, Meier M, Klein HH.
    J Endocrinol; 2004 Dec 16; 183(3):445-54. PubMed ID: 15590971
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT, Wang JS, Kajosaari LI, Laitila J, Neuvonen PJ, Backman JT.
    Basic Clin Pharmacol Toxicol; 2006 Jan 16; 98(1):79-85. PubMed ID: 16433896
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.